Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Apple
AAPL
|
+$391M |
| 2 |
Amazon
AMZN
|
+$361M |
| 3 |
Microsoft
MSFT
|
+$358M |
| 4 |
Meta Platforms (Facebook)
META
|
+$196M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$171M |
Top Sells
| 1 |
Alibaba
BABA
|
+$1.07B |
| 2 |
Newmont
NEM
|
+$141M |
| 3 |
Eli Lilly
LLY
|
+$125M |
| 4 |
Waste Management
WM
|
+$124M |
| 5 |
McDonald's
MCD
|
+$112M |
Sector Composition
| 1 | Technology | 27.15% |
| 2 | Healthcare | 14.17% |
| 3 | Consumer Discretionary | 13.28% |
| 4 | Communication Services | 11.57% |
| 5 | Industrials | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Vishay Precision Group
VPG
$398M
| $943K | ﹤0.01% |
27,700
+3,400
| +14% | +$116K |
|
|
TCS
2502
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $943K | ﹤0.01% |
+4,820
| New | +$943K |
|
2503
Bar Harbor Bankshares
BHB
$536M
| $942K | ﹤0.01% |
32,900
-1,200
| -4% | -$34.4K |
|
2504
SoundThinking
SSTI
$156M
| $941K | ﹤0.01% |
19,300
+900
| +5% | +$43.9K |
|
2505
Crinetics Pharmaceuticals
CRNX
$3.31B
| $935K | ﹤0.01% |
49,600
+12,000
| +32% | +$226K |
|
2506
Funko
FNKO
$182M
| $934K | ﹤0.01% |
+43,900
| New | +$934K |
|
2507
International Money Express
IMXI
$429M
| $934K | ﹤0.01% |
62,900
-2,200
| -3% | -$32.7K |
|
2508
Shattuck Labs
STTK
$90.1M
| $933K | ﹤0.01% |
+32,200
| New | +$933K |
|
2509
Oric Pharmaceuticals
ORIC
$1.02B
| $930K | ﹤0.01% |
52,600
-9,700
| -16% | -$172K |
|
2510
Alto Ingredients
ALTO
$88.2M
| $925K | ﹤0.01% |
151,400
-5,500
| -4% | -$33.6K |
|
2511
Waterstone Financial
WSBF
$276M
| $924K | ﹤0.01% |
47,000
-5,900
| -11% | -$116K |
|
2512
Avidity Biosciences
RNA
$6.18B
| $919K | ﹤0.01% |
37,200
+7,500
| +25% | +$185K |
|
|
LORL
2513
DELISTED
Loral Space and Communications, Inc.
LORL
| $917K | ﹤0.01% |
23,600
-3,300
| -12% | -$128K |
|
|
APR
2514
DELISTED
Apria, Inc. Common Stock
APR
| $913K | ﹤0.01% |
+32,600
| New | +$913K |
|
2515
Ardelyx
ARDX
$1.59B
| $905K | ﹤0.01% |
119,400
-14,700
| -11% | -$111K |
|
2516
Dorian LPG
LPG
$1.35B
| $903K | ﹤0.01% |
63,985
-2,500
| -4% | -$35.3K |
|
2517
C4 Therapeutics
CCCC
$193M
| $901K | ﹤0.01% |
+23,800
| New | +$901K |
|
|
NEWP
2518
New Pacific Metals
NEWP
$349M
| $900K | ﹤0.01% |
+186,860
| New | +$900K |
|
2519
Star Group
SGU
$394M
| $896K | ﹤0.01% |
80,003
-13,900
| -15% | -$156K |
|
|
TCRR
2520
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $894K | ﹤0.01% |
54,500
+2,100
| +4% | +$34.4K |
|
2521
Grid Dynamics Holdings
GDYN
$665M
| $891K | ﹤0.01% |
+59,300
| New | +$891K |
|
2522
Blue Bird Corp
BLBD
$1.85B
| $890K | ﹤0.01% |
35,811
+4,900
| +16% | +$122K |
|
|
KRON
2523
DELISTED
Kronos Bio
KRON
| $889K | ﹤0.01% |
+37,100
| New | +$889K |
|
2524
Gossamer Bio
GOSS
$630M
| $883K | ﹤0.01% |
108,800
-2,600
| -2% | -$21.1K |
|
|
PRVB
2525
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $883K | ﹤0.01% |
104,800
-2,700
| -3% | -$22.7K |
|